Short Interest in Senestech, Inc. (NASDAQ:SNES) Declines By 43.7%

Senestech, Inc. (NASDAQ:SNES) was the recipient of a large drop in short interest in March. As of March 13th, there was short interest totaling 27,834 shares, a drop of 43.7% from the February 26th total of 49,411 shares. Based on an average trading volume of 59,377 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.6% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Senestech presently has a consensus rating of “Hold”.

Insider Transactions at Senestech

In related news, major shareholder Glenbrook Capital Management acquired 146,249 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average price of $1.95 per share, with a total value of $285,185.55. Following the completion of the purchase, the insider directly owned 865,850 shares in the company, valued at approximately $1,688,407.50. The trade was a 20.32% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have bought a total of 344,988 shares of company stock worth $697,208 in the last ninety days. Insiders own 5.29% of the company’s stock.

Hedge Funds Weigh In On Senestech

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Sabby Management LLC raised its holdings in Senestech by 195.4% during the fourth quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock worth $451,000 after purchasing an additional 139,281 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after purchasing an additional 37,165 shares during the period. DRW Securities LLC raised its stake in shares of Senestech by 171.1% in the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after buying an additional 51,818 shares in the last quarter. Corsair Capital Management L.P. bought a new stake in shares of Senestech in the 2nd quarter worth $255,000. Finally, Jane Street Group LLC acquired a new stake in shares of Senestech in the second quarter valued at $161,000. 5.19% of the stock is currently owned by institutional investors and hedge funds.

Senestech Trading Down 4.0%

Shares of Senestech stock traded down $0.07 during trading hours on Friday, hitting $1.67. The company’s stock had a trading volume of 22,756 shares, compared to its average volume of 55,915. The company has a quick ratio of 11.36, a current ratio of 12.61 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $8.85 million, a PE ratio of -0.60 and a beta of 0.15. The business has a fifty day moving average of $2.00 and a 200 day moving average of $2.82. Senestech has a 1-year low of $1.30 and a 1-year high of $6.24.

Senestech (NASDAQ:SNES) last issued its quarterly earnings data on Thursday, March 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.01. Senestech had a negative net margin of 287.39% and a negative return on equity of 78.74%. The company had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.78 million. As a group, equities analysts forecast that Senestech will post -10.22 EPS for the current year.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.